State TN
Clinical Trials in Tennessee
Recruiting clinical trials with at least one study location in Tennessee. Data updated daily from ClinicalTrials.gov.
Top Conditions in Tennessee
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06660654 Phase 2
Recruiting
A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid...
Condition
Advanced Solid Tumor
Enrollment
200 pts
Location
United States, Belgium, China
Sponsor
Daiichi Sankyo
NCT07052370 Phase 1
Recruiting
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected...
Condition
Hematologic Malignancy
Enrollment
30 pts
Location
United States
Sponsor
St. Jude Children's Research H
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05668741 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
Condition
Cystic Fibrosis
Enrollment
39 pts
Location
United States, Australia, Belgium
Sponsor
Vertex Pharmaceuticals Incorpo
NCT06239272 Phase 1, Phase 2
Recruiting
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin...
Condition
Adipocytic Neoplasm
Enrollment
139 pts
Location
United States
Sponsor
St. Jude Children's Research H
NCT05544266 N/A
Recruiting
Rare and Atypical Diabetes Network
Condition
Diabetes Mellitus
Enrollment
2,000 pts
Location
United States
Sponsor
University of South Florida
NCT06979531 Phase 2
Recruiting
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Di...
Condition
Primary Sjögren's Syndrome
Enrollment
180 pts
Location
United States, Argentina, Brazil
Sponsor
Immunovant Sciences GmbH
NCT06414954 Phase 2
Recruiting
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia...
Condition
Myasthenia Gravis
Enrollment
84 pts
Location
United States, Belgium, Denmark
Sponsor
NMD Pharma A/S
NCT04337177 Phase 1
Recruiting
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatm...
Condition
Solid Tumors
Enrollment
20 pts
Location
United States
Sponsor
Valent Technologies, LLC
NCT01193075 N/A
Recruiting
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT...
Condition
Charcot Marie Tooth Disease
Enrollment
5,000 pts
Location
United States, Australia, Canada
Sponsor
Michael Shy
NCT06253871 Phase 1
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Condition
HER2 Mutation-Related Tumors
Enrollment
243 pts
Location
United States, France, Ireland
Sponsor
Iambic Therapeutics, Inc
NCT04747431 Phase 1, Phase 2
Recruiting
A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precurs...
Condition
Frontotemporal Dementia
Enrollment
30 pts
Location
United States, Australia, Brazil
Sponsor
Passage Bio, Inc.
NCT06321302 Phase 2
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diab...
Condition
Diabetic Retinopathy
Enrollment
178 pts
Location
United States, Germany, Hungary
Sponsor
Boehringer Ingelheim
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06378632 N/A
Recruiting
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE ...
Condition
Heart Failure
Enrollment
500 pts
Location
United States, Israel, Spain
Sponsor
Cordio Medical
NCT06971731 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phen...
Condition
Phenylketonuria
Enrollment
120 pts
Location
United States, Australia, France
Sponsor
Otsuka Pharmaceutical Developm
NCT04349436 Phase 1, Phase 2
Recruiting
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ...
Condition
Merkel Cell Carcinoma
Enrollment
90 pts
Location
United States
Sponsor
Replimune Inc.
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT05691244 Phase 3
Recruiting
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Is...
Condition
Acute Ischemic Stroke
Enrollment
514 pts
Location
United States, Germany, Spain
Sponsor
Pharmazz, Inc.
NCT06508814 N/A
Recruiting
Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy
Condition
Post Operative Pain
Enrollment
100 pts
Location
United States
Sponsor
University of Tennessee
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT03704207 N/A
Recruiting
Utility of PCD Diagnostics to Improve Clinical Care
Condition
Primary Ciliary Dyskinesia
Enrollment
200 pts
Location
United States
Sponsor
Vanderbilt University Medical
NCT05050136 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixib...
Condition
Primary Biliary Cholangitis
Enrollment
260 pts
Location
United States, Argentina, Belgium
Sponsor
Mirum Pharmaceuticals, Inc.
NCT07276399 Phase 3
Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared Wit...
Condition
Squamous Cell Carcinoma of Head and Neck
Enrollment
500 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development